Bkdal are employees and shareholders of Novo Nordisk A/S
Some participants actually gained lean tissue while losing fat on their GLP-1 medication
Some people achieve their target weight loss at 5 mg or 10 mg and stay there as their maintenance dose
The platform connects patients with licensed medical professionals while adhering to established care standards
They work by stimulating insulin release, reducing glucagon secretion, and slowing digestion, which helps maintain stable blood sugar levels
Whilst the precise cause of taste disturbances remains unclear, factors such as gastrointestinal effects, dehydration, concurrent medications, vitamin deficiencies, or oral health issues may contribute